The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Bernard Chevalier
Showing 1-20 of 39 articles
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials
Azzalini L,
Ellis S,
Kereiakes D,
Kimura T,
Gao R,
Onuma Y,
Chevalier B,
Dressler O,
Crowley A,
Zhou Z,
Redfors B,
Serruys P,
Stone G
December 17, 2021 | 10.4244/EIJ-D-21-00263
Clinical outcomes of the proximal optimisation technique (POT) in bifurcation stenting
Chevalier B,
Mamas MA,
Hovasse T,
Rashid M,
Gómez-Hospital JA,
Pan M,
Witkowski A,
Crowley J,
Aminian A,
McDonald J,
Beygui F,
Fernandez Portales J,
Roguin A,
Stankovic G
December 3, 2021 | 10.4244/EIJ-D-20-01393
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial
Watanabe Y,
Murasato Y,
Yamawaki M,
Kinoshita Y,
Okubo M,
Yumoto K,
Masuda N,
Otake H,
Aoki J,
Nakazawa G,
Numasawa Y,
Ito T,
Shite J,
Okamura T,
Takagi K,
Kozuma K,
Lefèvre T,
Chevalier B,
Louvard Y,
Suzuki N,
Kozuma K
October 20, 2021 | 10.4244/EIJ-D-20-01386
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iniguez-Romo A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M,
Polad J,
Hildick-Smith D,
Bizeau O,
Baisebenov R,
Roffi M,
Iniguez-Romo A,
Chevalier B,
von Birgelen C,
Roguin A,
Aminian A,
Angioi M,
Mamas MA
September 18, 2020 | 10.4244/EIJ-D-20-00361
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y,
Serruys P,
Tenekecioglu E,
Asano T,
Collet C,
Miyazaki Y,
Katsikis A,
Piek J,
Wykrzykowska J,
Chevalier B,
Mintz G,
Stone G,
Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska J,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Polymer-free drug-coated stents: workhorse or “niche horse”?
Urban P,
Chevalier B
September 20, 2018 | 10.4244/EIJV14I7A128
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Onuma Y,
Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy A,
Chevalier B,
Lefèvre T,
Louvard Y,
Segurado R,
Sawaya F,
Spaziano M,
Neylon A,
Serruys P,
Dawkins K,
Kappetein AP,
Mohr F,
Colombo A,
Feldman T,
Morice M
September 20, 2017 | 10.4244/EIJ-D-16-00991
Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes
Sanguineti F,
Garot P,
O’Connor S,
Watanabe Y,
Spaziano M,
Lefèvre T,
Hovasse T,
Benamer H,
Unterseeh T,
Chevalier B,
Morice M,
Louvard Y
February 3, 2017 | 10.4244/EIJ-D-15-00278
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
Chevalier B,
Onuma Y,
Van Boven A,
Piek J,
Sabaté M,
Helqvist S,
Baumbach A,
Smits P,
Kumar R,
Wasungu L,
Serruys P
October 20, 2016 | 10.4244/EIJY16M08_01
Patient-specific image-based computer simulation for the prediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valve
Schultz C,
Rodriguez-Olivares R,
Bosmans J,
Lefèvre T,
De Santis G,
Bruining N,
Collas V,
Dezutter T,
Bosmans B,
Rahhab Z,
Faquir N,
Watanabe Y,
Segers P,
Verhegghe B,
Chevalier B,
Van Mieghem N,
De Beule M,
Mortier P,
de Jaegere P
January 20, 2016 | 10.4244/EIJV11I9A212
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
Bourantas C,
Serruys P,
Nakatani S,
Zhang Y-J,
Farooq V,
Diletti R,
Ligthart J,
Sheehy A,
van Geuns R,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Rapoza R,
Veldhof S,
Onuma Y,
Garcia-Garcia H
November 20, 2015 | 10.4244/EIJY14M10_06
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial
Chevalier B,
Wijns W,
Silber S,
Garcia E,
Serra A,
Paunovic D,
Serruys P
September 22, 2015 | 10.4244/EIJY14M12_13
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
Costa Jr J,
Abizaid A,
Bartorelli A,
Whitbourn R,
van Geuns R,
Chevalier B,
Perin M,
Seth A,
Botelho R,
Serruys P
June 19, 2015 | 10.4244/EIJY15M05_06
The future of BRS in bifurcations
Kraak R,
Grundeken M.J,
Onuma Y,
Tu S,
Wykrzykowska J,
Chevalier B,
Ormiston J,
Serruys P
May 19, 2015 | 10.4244/EIJV11SVA45
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A,
Costa Jr J,
Bartorelli A,
Whitbourn R,
van Geuns R,
Chevalier B,
Patel T,
Seth A,
Stuteville M,
Dorange C,
Cheong W-F,
Sudhir K,
Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C,
Farooq V,
Zhang Y-J,
Muramatsu T,
Gogas B,
Thuesen L,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Dorange C,
Rapoza R,
Onuma Y,
Garcia-Garcia H,
Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
1
2
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke